Chunkit Fung

4.2k total citations
110 papers, 2.3k citations indexed

About

Chunkit Fung is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chunkit Fung has authored 110 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 41 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chunkit Fung's work include Testicular diseases and treatments (32 papers), Cancer survivorship and care (20 papers) and Cancer Treatment and Pharmacology (15 papers). Chunkit Fung is often cited by papers focused on Testicular diseases and treatments (32 papers), Cancer survivorship and care (20 papers) and Cancer Treatment and Pharmacology (15 papers). Chunkit Fung collaborates with scholars based in United States, Canada and Norway. Chunkit Fung's co-authors include Lois B. Travis, Sophie D. Fosså, David J. Vaughn, Supriya G. Mohile, Clair J. Beard, Shirin Ardeshir‐Rouhani‐Fard, Michael T. Milano, Karen M. Mustian, Paul C. Dinh and Deepak M. Sahasrabudhe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chunkit Fung

103 papers receiving 2.3k citations

Peers

Chunkit Fung
Jong Doo Lee South Korea
Aubrey Milunsky United States
John Henley United States
D. Testa Italy
Guiting Lin United States
H. Sauer Germany
Chunkit Fung
Citations per year, relative to Chunkit Fung Chunkit Fung (= 1×) peers Jakob Eberhard

Countries citing papers authored by Chunkit Fung

Since Specialization
Citations

This map shows the geographic impact of Chunkit Fung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunkit Fung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunkit Fung more than expected).

Fields of papers citing papers by Chunkit Fung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunkit Fung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunkit Fung. The network helps show where Chunkit Fung may publish in the future.

Co-authorship network of co-authors of Chunkit Fung

This figure shows the co-authorship network connecting the top 25 collaborators of Chunkit Fung. A scholar is included among the top collaborators of Chunkit Fung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunkit Fung. Chunkit Fung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stojanovski, Kristefer, et al.. (2025). Disparities in the cancer continuum experienced by transgender and gender‐diverse patients: A rapid review. Cancer. 131(5). e35788–e35788. 1 indexed citations
2.
Kerns, Sarah L., Paul C. Dinh, Patrick O. Monahan, et al.. (2025). Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer. JNCI Journal of the National Cancer Institute. 117(9). 1797–1808. 1 indexed citations
3.
Peppone, Luke J., Amber S. Kleckner, Chunkit Fung, et al.. (2024). High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT. Cancer. 130(14). 2538–2551. 6 indexed citations
4.
Dinh, Paul C., Patrick O. Monahan, Chunkit Fung, et al.. (2024). Cognitive function in long-term testicular cancer survivors: impact of modifiable factors. JNCI Cancer Spectrum. 8(5). 2 indexed citations
5.
Sanchez, Victoria A., Megan M. Shuey, Paul C. Dinh, et al.. (2023). Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy. Journal of Clinical Oncology. 41(12). 2211–2226. 23 indexed citations
6.
Dinh, Paul C., Patrick O. Monahan, Sophie D. Fosså, et al.. (2023). Impact of pain and adverse health outcomes on long-term US testicular cancer survivors. JNCI Journal of the National Cancer Institute. 116(3). 455–467. 7 indexed citations
7.
Lin, Po‐Ju, Brian J. Altman, Nikesha Gilmore, et al.. (2023). Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors. Journal of the National Comprehensive Cancer Network. 21(2). 153–162.e2. 10 indexed citations
8.
Torous, Dorothea K., Svetlana L. Avlasevich, Jeffrey C. Bemis, et al.. (2023). Lack of hydroxyurea‐associated mutagenesis in pediatric sickle cell disease patients. Environmental and Molecular Mutagenesis. 64(3). 167–175. 5 indexed citations
9.
Dinh, Paul C., Victoria A. Sanchez, Matthew R. Trendowski, et al.. (2022). Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer. Cancer Medicine. 12(3). 2999–3012. 3 indexed citations
10.
Trendowski, Matthew R., Emma Wilkinson, Paul C. Dinh, et al.. (2022). Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. Cancer Medicine. 11(14). 2801–2816. 11 indexed citations
11.
Trendowski, Matthew R., Heather E. Wheeler, Darren R. Feldman, et al.. (2020). Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors. Clinical Cancer Research. 26(24). 6550–6558. 9 indexed citations
12.
Kilari, Deepak, Jason Zittel, Arpan Patel, et al.. (2020). 677P A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Final analysis. Annals of Oncology. 31. S540–S541. 1 indexed citations
13.
Fung, Chunkit, Evelyn Herrmann, Ekin Ermiş, et al.. (2019). P1.04-05 PD-L1 Expression (SP263) in Lung Cancer and Paired Brain Metastases – A Single Center Study in 211 Patients. Journal of Thoracic Oncology. 14(10). S440–S440. 1 indexed citations
14.
Lin, Po‐Ju, Luke J. Peppone, Michelle C. Janelsins, et al.. (2018). Yoga for the Management of Cancer Treatment-Related Toxicities. Current Oncology Reports. 20(1). 5–5. 35 indexed citations
15.
Dolan, M. Eileen, Heather E. Wheeler, Eric R. Gamazon, et al.. (2017). Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer. Clinical Cancer Research. 23(19). 5757–5768. 63 indexed citations
16.
Fung, Chunkit, Howard D. Sesso, AnnaLynn M. Williams, et al.. (2017). Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. Publisher. 1 indexed citations
17.
Mustian, Karen M., Calvin L. Cole, Po‐Ju Lin, et al.. (2016). Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments. Seminars in Oncology Nursing. 32(4). 383–393. 27 indexed citations
18.
Loh, Kah Poh, et al.. (2016). Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma. Clinical Genitourinary Cancer. 14(4). e449–e452. 13 indexed citations
19.
Fung, Chunkit, et al.. (2015). Secondary malignant neoplasms in testicular cancer survivors. Urologic Oncology Seminars and Original Investigations. 33(9). 392–398. 31 indexed citations
20.
Vitek, Wendy, Michelle Shayne, Kathleen M. Hoeger, et al.. (2014). Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. Fertility and Sterility. 102(3). 808–815.e1. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026